Home » Stocks » TNDM

Tandem Diabetes Care, Inc. (TNDM)

Stock Price: $90.75 USD -0.45 (-0.49%)
Updated November 27, 1:00 PM EST - Market closed
After-hours: $90.99 +0.24 (0.26%) Nov 27, 4:59 PM

Stock Price Chart

Key Info

Market Cap 5.64B
Revenue (ttm) 439.16M
Net Income (ttm) -48.73M
Shares Out 62.19M
EPS (ttm) -0.81
PE Ratio n/a
Forward PE 1,000.00
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $90.75
Previous Close $91.20
Change ($) -0.45
Change (%) -0.49%
Day's Open 91.59
Day's Range 90.09 - 92.58
Day's Volume 329,746
52-Week Range 43.69 - 123.74

More Stats

Market Cap 5.64B
Enterprise Value 5.41B
Earnings Date (est) Mar 2, 2021
Ex-Dividend Date n/a
Shares Outstanding 62.19M
Float 60.16M
EPS (basic) -0.80
EPS (diluted) -0.81
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.82M
Short Ratio 4.15
Short % of Float 4.69%
Beta 0.47
PE Ratio n/a
Forward PE 1,000.00
P/FCF Ratio n/a
PS Ratio 12.85
PB Ratio 17.79
Revenue 439.16M
Operating Income -24.48M
Net Income -48.73M
Free Cash Flow -1.19M
Net Cash 238.14M
Net Cash / Share 3.83
Gross Margin 44.22%
Operating Margin -5.57%
Profit Margin -11.10%
FCF Margin -0.27%
ROA -3.17%
ROE -19.75%
ROIC -10.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (15)

Buy 9
Overweight 2
Hold 4
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(42.29% upside)
Current: $90.75
Target: 129.13
*Average 12-month price target from 15 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth97.05%70.88%27.72%15.65%46.51%71.41%1072%--
Gross Profit19489.8244.0923.5926.5815.256.17-1.35-
Operating Income-16.72-44.63-62.94-78.05-69.00-75.66-49.43-33.05-24.21
Net Income-24.75-123-73.03-83.45-72.42-79.52-63.14-33.02-25.51
Shares Outstanding58.5148.135.683.062.892.330.290.020.02
Earnings Per Share-0.42-2.55-12.87-27.30-25.04-34.17-214.60-1,758.80-1,498.70
Operating Cash Flow41.91-8.32-66.14-61.17-58.76-61.38-47.76-33.47-21.55
Capital Expenditures-19.54-2.99-5.72-8.93-5.76-4.41-4.01-4.53-1.32
Free Cash Flow22.36-11.31-71.85-70.10-64.53-65.78-51.77-38.00-22.87
Cash & Equivalents17612914.1855.5473.1169.2813217.21-
Total Debt20.38-76.5478.9629.2829.4429.404.20-
Net Cash / Debt156129-62.36-23.4243.8339.8410213.01-
Book Value195131-29.15-5.9363.4754.57116-106-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Tandem Diabetes Care, Inc.
Country United States
Employees 1,043
CEO John F. Sheridan

Stock Information

Ticker Symbol TNDM
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: TNDM
IPO Date November 14, 2013


Tandem Diabetes Care, a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin delivery system with Basal-IQ Technology; t:slim X2 with control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Further, the company offers Sugarmate, a mobile app for people with diabetes who use insulin. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.